Assignment of Assignor's Interest

Recorded: 2022-07-05 Pages: 17

Assignors

LI, CHI-CHUNG

Executed: 2022-04-27

O'HEAR, CAROL ELAINE

Executed: 2021-10-05

CHEN, XI

Executed: 2022-04-27

Assignee

GENENTECH, INC.

1 DNA WAY, SOUTH SAN FRANCISCO, CALIFORNIA, 94080

Covered Properties (2)

Methods for Treatment of B Cell Proliferative Disorders with Anti-CD20/Anti-CD3 Bispecific Antibodies

Application: 63/195,677 →

Methods for Treatment of B Cell Proliferative Disorders with Anti-CD20/Anti-CD3 Bispecific Antibodies

Application: 17/829,807 →

Publication: US 2022/0380466